382 related articles for article (PubMed ID: 27601215)
1. Application of The Paris System to atypical urine cytology samples: correlation with histology and UroVysion
Miki Y; Neat M; Chandra A
Cytopathology; 2017 Apr; 28(2):88-95. PubMed ID: 27601215
[TBL] [Abstract][Full Text] [Related]
2. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
[TBL] [Abstract][Full Text] [Related]
3. Atypical Category of the Johns Hopkins Template Has Higher Risk of Malignancy than the Paris System but the Paris System Is More Applicable for Suspicious Category.
Celik B; Kavas G
Acta Cytol; 2023; 67(4):425-433. PubMed ID: 36731438
[TBL] [Abstract][Full Text] [Related]
4. Cytohistological correlation of urine cytology in a tertiary centre with application of the Paris system.
Rohilla M; Singh P; Rajwanshi A; Gupta N; Srinivasan R; Dey P; Kakkar N
Cytopathology; 2018 Oct; 29(5):436-443. PubMed ID: 29920811
[TBL] [Abstract][Full Text] [Related]
5. The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH.
Vlajnic T; Gut A; Savic S; Bubendorf L
J Clin Pathol; 2020 Feb; 73(2):90-95. PubMed ID: 31467041
[TBL] [Abstract][Full Text] [Related]
6. The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection.
Zheng X; Si Q; Du D; Harshan M; Zhang Z; Haines K; Shi W; Chhieng DC
Cytopathology; 2018 Apr; 29(2):184-188. PubMed ID: 29251368
[TBL] [Abstract][Full Text] [Related]
7. Clinical follow up and the impact of the Paris system in the assessment of patients with atypical urine cytology.
Northrup V; Acar BC; Hossain M; Acker MR; Manuel E; Rahmeh T
Diagn Cytopathol; 2018 Dec; 46(12):1022-1030. PubMed ID: 30375194
[TBL] [Abstract][Full Text] [Related]
8. The application of the Johns Hopkins Hospital Template on urine cytology.
Wu HH; Redelman M; Chen S; Grignon DJ; Cramer HM
Diagn Cytopathol; 2015 Aug; 43(8):593-7. PubMed ID: 25721938
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Paris System in atypical urinary cytology.
Mikou P; Lenos M; Papaioannou D; Vrettou K; Trigka EA; Sousouris S; Constantinides C
Cytopathology; 2018 Dec; 29(6):545-549. PubMed ID: 30066427
[TBL] [Abstract][Full Text] [Related]
10. Effect of the Paris system for reporting urinary cytology with histologic follow-up.
Rohra P; Ocampo Gonzalez FA; Yan L; Mir F; Furlan K; Basu S; Barua A; Cheng L; Park JW
Diagn Cytopathol; 2021 Jun; 49(6):691-699. PubMed ID: 33600080
[TBL] [Abstract][Full Text] [Related]
11. Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow-up.
Khajir G; Sun T; Wang H; Sprenkle PC; Adeniran AJ; Cai G; Levi AW
Cytopathology; 2024 Mar; 35(2):235-241. PubMed ID: 37916579
[TBL] [Abstract][Full Text] [Related]
12. Modification of The Paris System for urinary tract washing specimens using diagnostic cytological features.
Suh J; Go H; Sung C; Baek S; Hwang H; Jeong S; Cho Y
Cytopathology; 2017 Dec; 28(6):516-523. PubMed ID: 28816366
[TBL] [Abstract][Full Text] [Related]
13. Impact of Implementing the Paris System for Reporting Urine Cytology in the Performance of Urine Cytology: A Correlative Study of 124 Cases.
Hassan M; Solanki S; Kassouf W; Kanber Y; Caglar D; Auger M; Brimo F
Am J Clin Pathol; 2016 Sep; 146(3):384-90. PubMed ID: 27543983
[TBL] [Abstract][Full Text] [Related]
14. Two-year study on the application of the Paris system for urinary cytology in a cancer centre.
de Paula R; Oliveira A; Nunes W; Bovolim G; Domingos T; De Brot L; Bezerra S; Cunha I; Morini M; Saieg M
Cytopathology; 2020 Jan; 31(1):41-46. PubMed ID: 31654587
[TBL] [Abstract][Full Text] [Related]
15. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value of 0.5 for atypical urothelial cells.
Hang JF; Charu V; Zhang ML; VandenBussche CJ
Cancer Cytopathol; 2017 Sep; 125(9):710-716. PubMed ID: 28581671
[TBL] [Abstract][Full Text] [Related]
16. Significant reduction of indeterminate (atypical) diagnosis after implementation of The Paris System for Reporting Urinary Cytology: A single-institution study of more than 27,000 cases.
Tian W; Shore KT; Shah RB
Cancer Cytopathol; 2021 Feb; 129(2):114-120. PubMed ID: 32931158
[TBL] [Abstract][Full Text] [Related]
17. Comparison of urine cytology diagnostic reports before and after the implementation of the Paris System classification system in China.
Ma C; Zhang L
Cytopathology; 2020 Sep; 31(5):457-462. PubMed ID: 32246545
[TBL] [Abstract][Full Text] [Related]
18. Causes of false-negative for high-grade urothelial carcinoma in urine cytology.
Lee PJ; Owens CL; Lithgow MY; Jiang Z; Fischer AH
Diagn Cytopathol; 2016 Dec; 44(12):994-999. PubMed ID: 27781412
[TBL] [Abstract][Full Text] [Related]
19. Split-sample comparison of urothelial cells in ThinPrep and cytospin preparations in urinary cytology: Do we need to adjust The Paris System for Reporting Urinary Cytology criteria?
Richardson CJ; Pambuccian SE; Barkan GA
Cancer Cytopathol; 2020 Feb; 128(2):119-125. PubMed ID: 31774630
[TBL] [Abstract][Full Text] [Related]
20. Should the BK polyomavirus cytopathic effect be best classified as atypical or benign in urine cytology specimens?
Allison DB; Olson MT; Lilo M; Zhang ML; Rosenthal DL; VandenBussche CJ
Cancer Cytopathol; 2016 Jun; 124(6):436-42. PubMed ID: 26929126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
